Leaderboard

En | De
Sie sind hier: Urologie-Nephrologie » Tumoren/BPH 19. Januar 2021
Suchen
medline.ch
Tumoren/BPH
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Entzündung-Infekt
Nephrolithiasis
Niereninsuffizienz
Sexualität
Tumoren/BPH
Anderes
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 6999  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 139975  
   
Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer.
Abdom Radiol (NY)
Valentin B, Schimmöller L, Ullrich T, Klingebiel M, Demetrescu D, Sawicki LM, Lakes J, Mally D, Quentin M, Esposito I, Albers P, Antoch G, Arsov C.
PMID: 33452898 [PubMed - as supplied by publisher]


Clinical implications of genomic alterations in metastatic prostate cancer.
Prostate Cancer Prostatic Dis
Sumiyoshi T, Chi KN, Wyatt AW.
PMID: 33452452 [PubMed - as supplied by publisher]


Randomized phase II trial of sipuleucel-T with or without radium-223 in men with bone-metastatic castration-resistant prostate cancer.
Clin Cancer Res
Marshall CH, Fu W, Wang H, Park JC, DeWeese TL, Tran PT, Song DY, King S, Afful M, Hurrelbrink J, Manogue CE, Cotogno P, Moldawer NP, Barata P, Drake CG, Posadas EM, Armstrong AJ, Sartor O, Antonarakis ES.
PMID: 33451978 [PubMed - as supplied by publisher]


Efficacy of Advance Care Planning Videos for Patients: A Randomized Controlled Trial in Cancer, Heart, and Kidney Failure Outpatient Settings.
Med Decis Making
Douglas ML, Simon J, Davison SN, Biondo P, Ghosh S, Kassam A, Fassbender K.
PMID: 33451263 [PubMed - as supplied by publisher]


Assessing Health-Related Quality of Life Among Survivors of Testicular Cancer: A Systematic Review.
Am J Mens Health
Rovito MJ, Bruzzone A, Lee E, López Castillo H, Talton W, Taliaferro L, Falk D.
PMID: 33451261 [PubMed - as supplied by publisher]


Recent Advances in Nanomedicine for the Diagnosis and Treatment of Prostate Cancer Bone Metastasis.
Molecules
Hagaman DE, Damasco JA, Perez JVD, Rojo RD, Melancon MP.
PMID: 33450939 [PubMed - as supplied by publisher]


Factors Associated with Refusal or Discontinuation of Treatment in Patients with Bladder Cancer: A Cohort Population-Based Study in Taiwan.
Int J Environ Res Public Health
Chang NT, Chang YH, Huang YT, Chen SC.
PMID: 33450864 [PubMed - as supplied by publisher]


Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers.
Diagnostics (Basel)
Luining WI, Meijer D, Dahele MR, Vis AN, Oprea-Lager DE.
PMID: 33450817 [PubMed - as supplied by publisher]


Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies.
J Control Release
Sun W, Deng Y, Zhao M, Jiang Y, Gou J, Wang Y, Yin T, Zhang Y, He H, Tang X.
PMID: 33450321 [PubMed - as supplied by publisher]


Extracellular vesicle-transferred long noncoding RNAs in bladder cancer.
Clin Chim Acta
Xue M, Chen W, Li X.
PMID: 33450212 [PubMed - as supplied by publisher]


Evaluation of Aspirin Use With Cancer Incidence and Survival Among Older Adults in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
JAMA Netw Open
Loomans-Kropp HA, Pinsky P, Umar A.
PMID: 33449095 [PubMed - as supplied by publisher]


Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: Individual patient data meta-analyses.
Psychooncology
Abrahams HJG, Knoop H, Schreurs M, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Aitken JF, Arving C, Brandberg Y, Chambers SK, Gielissen MFM, Glimelius B, Goedendorp MM, Graves KD, Heiney SP, Horne R, Hunter MS, Johansson B, Northouse LL, Oldenburg HSA, Prins JB, Savard J, van Beurden M, van den Berg SW, Verdonck-de Leeuw IM, Buffart LM.
PMID: 33448521 [PubMed - in process]


Multiparametric MRI in the management of prostate cancer: an update-a narrative review.
Gland Surg
Ziglioli F, Maestroni U, Manna C, Negrini G, Granelli G, Greco V, Pagnini F, De Filippo M.
PMID: 33447583 [PubMed]


Biparametric (bp) and multiparametric (mp) magnetic resonance imaging (MRI) approach to prostate cancer disease: a narrative review of current debate on dynamic contrast enhancement.
Gland Surg
Palumbo P, Manetta R, Izzo A, Bruno F, Arrigoni F, De Filippo M, Splendiani A, Di Cesare E, Masciocchi C, Barile A.
PMID: 33447576 [PubMed]


Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study.
Sci Rep
Liu Y, Zhang P, Zhang Y, Zheng L, Xu W, Hou D, Kang Z.
PMID: 33446816 [PubMed - in process]


Commentary: Future Directions in Bladder Cancer Care.
Semin Oncol Nurs
Jensen BT, Lauridsen SV.
PMID: 33446381 [PubMed - as supplied by publisher]


Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Bladder Cancer Patients: A Multicentre Comparative Effectiveness Study.
Eur Urol
Wijburg CJ, Michels CTJ, Grutters JPC, Rovers MM, Alfred Witjes J, RACE Study Group..
PMID: 33446375 [PubMed - as supplied by publisher]


Immune Escape in Prostate Cancer: Known and Predicted Mechanisms and Targets.
Urol Clin North Am
Reva BA, Omelchenko T, Nair SS, Tewari AK.
PMID: 33446324 [PubMed - in process]


The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer.
Urol Clin North Am
Nair SS, Weil R, Dovey Z, Davis A, Tewari AK.
PMID: 33446323 [PubMed - in process]


Double-Stranded RNA Immunomodulators in Prostate Cancer.
Urol Clin North Am
Salazar AM, Celis E.
PMID: 33446322 [PubMed - in process]


   
   Artikel 1 - 20 / 139975    Seite 1 von 6999  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

  Zeitfenster  
   

Sky right 1